e-learning
resources
Vienna 2009
Monday, 14.09.2009
Drug effects in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data
M. Cazzola, I. Floriani, C. P. Page (Roma, Milano, Italy; London, United Kingdom)
Source:
Annual Congress 2009 - Drug effects in COPD
Session:
Drug effects in COPD
Session type:
Thematic Poster Session
Number:
2006
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cazzola, I. Floriani, C. P. Page (Roma, Milano, Italy; London, United Kingdom). Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data. Eur Respir J 2009; 34: Suppl. 53, 2006
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005
Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 55s
Year: 2005
Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009
Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003
The effect of dipyrone on respiratory function in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 515s
Year: 2001
Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study
Source: Eur Respir J 2012; 40: 28-36
Year: 2012
The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011
7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001
Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Long-term health status in patients with poorly reversible chronic obstructive pulmonary disease (COPD) treated with cilomilast
Source: Eur Respir J 2004; 24: Suppl. 48, 540s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept